Navigation Links
Genesis I Total Knee System

ProductsGenesis I Total Knee System
Company Smith & Nephew, Inc. - Orthopedics
Item Genesis I Total Knee System
Features 
  • A deeper, more lateralized trochlear groove improves patellar contact and tracking.
  • An externally rotated femoral implant design optimizes femorotibial rotational alignment and reduces the likelihood of notching the lateral anterior cortex.
  • Anatomically-shaped tibial baseplates have an improved fin design and significantly improve coverage of the tibia as compared to symmetrical designs.
  • Versatile, simple instrumentation, comprehensive in function and fewer in number, reduces surgical time, makes intraoperative management easier, and provides a more precise fit.
  • Thoughtful versatility reduces the number of implant components yet significantly expands your clinical options.
  • Wear is reduced by improving contact area and reducing contact stress in all articular surfaces.
  • All articular surfaces are polished, including the proximal tibia. A nondegrading form of sterilization is used on all polyethylene.
  • Dedicated cruciate retaining, posterior stabilized, low demand, and revision systems have been designed to meet the individual needs of each clinical and economic situation.
    • Description The Genesis Total Knee System provides the adaptability surgeons need to make each implant fit each patient. Not the other way around. The wide selection of stems, wedges, modules, articular inserts and patellar components allow surgeons to address the unexpected - with certainty. And you do it all with one instrument set. For cruciate retention. Or posterior stabilization. For primary knee arthroplasty. Or revision procedures. This system is intended for cemented use only.
    Info Smith & Nephew, Inc. - Orthopedics
    Customer Service: (800) 821-5700
    Web site: http://www.smith-nephew.com/

    Related medicine products :

    1. Genesis
    2. Genesis FE500 Workcell
    3. Genesis II Total Knee System
    4. Genesis II* Total Knee System
    5. Genesis II Tibial Instrumentation
    6. Genesis II Revision Instrumentation
    7. Genesis II Femoral Instrumentation
    8. Genesis II Patellar Instruments
    9. Genesis II® Total Knee System
    10. Genesis NPS
    11. Genesis RMP
    Breaking Medicine News(10 mins):Health News:Allscripts Launches New Innovations in Live Event 2Health News:Allscripts Launches New Innovations in Live Event 3Health News:Allscripts Launches New Innovations in Live Event 4Health News:Allscripts Launches New Innovations in Live Event 5Health News:Allscripts Launches New Innovations in Live Event 6Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 2Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 3Health News:Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium 2Health News:Agendia to Present Broad Array of Data at 2009 San Antonio Breast Cancer Symposium 3Health News:Anesiva Receives NASDAQ Listing Compliance Notice 2Health News:Anesiva Receives NASDAQ Listing Compliance Notice 3Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 2Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 3Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 4
    Breaking Medicine Technology:Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Patent Expiries of Blockbuster Antibiotics Will Fuel a Decline of More Than 15 Percent in the Community-Acquired Pneumonia Drug Market 2Stater Bros Raises 24266 429 00 for the Leukemia 26 Lymphoma Society 54232 1Stater Bros Raises 24266 429 00 for the Leukemia 26 Lymphoma Society 54232 2Epix Pharmaceuticals Inc Announces PRX 07034 Therapeutics CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 54229 1Epix Pharmaceuticals Inc Announces PRX 07034 Therapeutics CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 54229 2The public overestimates benefits of cancer screening survey finds 54226 1